{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:01:10Z","timestamp":1767337270370},"reference-count":18,"publisher":"Elsevier BV","issue":"9200","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1016\/s0140-6736(00)00019-2","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T01:30:23Z","timestamp":1027647023000},"page":"248-250","source":"Crossref","is-referenced-by-count":111,"title":["New insights into role of microenvironment in multiple myeloma"],"prefix":"10.1016","volume":"355","author":[{"given":"Guido","family":"Tricot","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(00)00019-2_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0301-472X(99)00061-2","article-title":"Cell biology of the osteoclast","volume":"27","author":"Roodman","year":"1999","journal-title":"Exptl Hematol"},{"key":"10.1016\/S0140-6736(00)00019-2_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(00)00019-2_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0140-6736(00)00019-2_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.leu.2400892","article-title":"In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates","volume":"12","author":"Aparicio","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/S0140-6736(00)00019-2_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(00)00019-2_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4049\/jimmunol.160.1.395","article-title":"Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, and Ig superfamily member","volume":"160","author":"Deaglio","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(00)00019-2_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.1999.01321.x","article-title":"Human myeloma cells express the CD38 ligand CD31","volume":"105","author":"Vallario","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/S0140-6736(00)00019-2_bib8","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/MCB.17.7.4015","article-title":"Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis","volume":"17","author":"Yoshida","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0140-6736(00)00019-2_bib9","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood.V94.6.1878","article-title":"Nuclear factor-KB-dependent induction of interleukin-8 gene expression by tumor necrosis factor a: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation","volume":"94","author":"Vlahopoulos","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(00)00019-2_bib10","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix methalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(00)00019-2_bib11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(00)00019-2_bib12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-KB","volume":"87","author":"Chauhan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(00)00019-2_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2141.1999.01705.x","article-title":"Mcl-1 and BCl-xL are co-regulated by IL-6 in human myeloma cells","volume":"107","author":"Puthier","year":"1999","journal-title":"Br J Haemutol"},{"key":"10.1016\/S0140-6736(00)00019-2_bib14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V86.5.1903.bloodjournal8651903","article-title":"Expression of Bcl-xL can confer a multidrug resistance phenotype","volume":"86","author":"Minn","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(00)00019-2_bib15","first-page":"1489","article-title":"Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis","volume":"13","author":"Cherbonnel-Lassserre","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/S0140-6736(00)00019-2_bib16","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(00)00019-2_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/10577","article-title":"Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-KB","volume":"5","author":"Wang","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(00)00019-2_bib18","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood.V88.5.1805.1805","article-title":"Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide","volume":"88","author":"Tu","year":"1996","journal-title":"Blood"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T13:35:57Z","timestamp":1681652157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673600000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":18,"journal-issue":{"issue":"9200","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0140673600000192"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(00)00019-2","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}